Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 73231

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : April | Volume : 17 | Issue : 4 | Page : OC13 - OC16 Full Version

Prevalence and Risk Factors of Pulmonary Arterial Hypertension in Interstitial Lung Diseases: A Cross-sectional Study


Published: April 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/60250.17734
Kondala Rao Kola, Mounica Pusarla, Hitesh Cheran Kurudamannil, Bandhavi Sayyapureddi

1. Associate Professor, Department of Pulmonary Medicine, Medicine GSL Medical College, Rajahmundry, Andhra Pradesh, India. 2. Resident, Department of Pulmonary Medicine, GSL Medical College, Rajahmundry, Andhra Pradesh, India. 3. Resident, Department of Pulmonary Medicine, GSL Medical College, Rajahmundry, Andhra Pradesh, India. 4. Resident, Department of Pulmonary Medicine, GSL Medical College, Rajahmundry, Andhra Pradesh, India.

Correspondence Address :
Kondala Rao Kola,
Associate Professor, Department of Pulmonary Medicine, GSL Medical College, NH 16, Rajahmundry, Andhra Pradesh, India.
E-mail: kkraodr@gmail.com

Abstract

Introduction: Interstitial Lung Diseases (ILD) is associated with inflammatory and/or fibrotic changes in the lungs. Pulmonary Arterial Hypertension (PAH) is a complication of many end-stage lung diseases due to the remodelling of pulmonary vasculature associated with hypoxia leading to pulmonary vascular resistance. The Association of PAH in ILD contributes significantly to high morbidity and mortality. ILD being a progressive disease it is difficult to predict when the PAH will set in.

Aim: To assess the clinical and radiological profiles of patients with ILD and to associate these with the severity of PAH.

Materials and Methods: The present cross-sectional study was conducted in the Department of Respiratory Medicine at GSL Medical College on 23 patients with ILD from 1st October 2019 to 31st August 2021, in GSL Medical College and Hospital, Andhra Pradesh. Each patient was subjected to Chest X-ray (CXR), Electrocardiogram (ECG), and 2-Dimensional Echocardiogram (2D ECHO). Evidence of PAH in any one investigation was considered. In ECG reports evidence of right ventricular enlargement (R>S in V1/V2 and right axis deviation >110 degrees, R=11 mm) was considered as PAH. CXR showing dilatation of the pulmonary artery with an increased cardiothoracic ratio was considered as PAH. A 2-D ECHO was performed to estimate the right arterial pressure and evidence of pulmonary arterial systemic pressure of >40 mmHg was considered as PAH. All the data were statistically analysed by using IBM Statistical Package for Social Sciences (SPSS) version 20.0.

Results: Fifty-two percent of the population constituted females, and the mean age of the whole population was 59.7±14.4 years and the majority of them (65%) belonged to upper lower socio-economic class. Usual Interstitial Pneumonia (UIP) was the most common pattern observed accounting for 57%. Prevalence of PAH was 65% with a longer duration of symptoms, 57% of the population had grade 3 of Modified Medical Research Council (MMRC) dyspnoea and 52.17% covered less than 200 metres in the 6-Minute Walk Test (6-MWT). Oxygen desaturation after 6-MWT was observed to be the contributing factor for the development of severe pulmonary hypertension in ILD patients.

Conclusion: Factors like delayed seeking of medical care, co-morbidity like hypertension, higher grades of dyspnoea at the time of presentation, shorter 6MWD, and postwalk oxygen saturation were found to be predictors of pulmonary artery hypertension in patients with ILD. Early recognition of these risk factors in patients with ILD and the prompt treatment of the disease can reduce the development of severe PAH.

Keywords

Chest X-ray, Dyspnoea, Echocardiogram, Electrocardiogram, Hypoxia

The interstitial lung diseases are a heterogeneous group of lung diseases associated with inflammatory and fibrotic changes in the lungs (1). PAH is a very common occurrence in ILDs which deteriorates the quality of life in individuals. It occurs due to the remodelling of pulmonary vasculature associated with hypoxia leading to pulmonary vascular resistance (2). The occurrence of PAH in ILDs leads to an increase in mortality (3),(4). ILDs have a progressive course and it is difficult to predict when PAH develops. A multicentric study showed that ILD due to systemic sclerosis has a higher mortality risk in comparison to idiopathic PAHs (5). Another study also observed the development of PAH in mild ILD in systemic sclerosis patients (6). Ryu JH et al., suggest progressive parenchymal and perivascular fibrosis, vascular inflammation, etc., are contributing factors to the development of PAH (7). All this literature hints towards the causes of PAH particularly in patients with ILD associated with Connective Tissue Disorders-ILD (CTD-ILD).

In CTD-ILDs vascular involvements are more due to the involvement of the connective tissues. But ILD due to other known and unknown aetiologies also leads to PAH in most instances. But it is difficult to predict who will develop this complication earlier. Very few studies have been conducted to assess the risk factors for the development of PAH in patients with ILDs. The present study was intended to predict the risk factors contributing to PAH in patients with ILDs. The objectives were to assess the clinical and radiological profiles of patients with ILDs and to associate them with the severity of PAH in the patients.

Material and Methods

The present cross-sectional study conducted in the Department of Respiratory Medicine at GSL Medical College, Rajahmundry, Andhra Pradesh, India, on 23 patients with ILD from 1st October 2019 to 31st August 2021. This study was approved by the Institutional Ethical Committee and institutional review board (GSLMC/RC: 565-EC/565-09/19).

Dyspnoea was graded using MMRC grading system. According to MMRC, dyspnoea was classified into 5 grades. Grade 0 to grade 4. Grade 0 represents breathlessness only with strenuous exercise, while grade 4 represents too breathlessness to leave the house or on dressing or undressing. Higher the grade number, higher the severity of dyspnoea.

Inclusion criteria: All patients who were diagnosed with ILD based on history, clinical examination, and High-resolution Computed Tomography (HRCT). Patients’ presentations like dry cough, and progressive dyspnoea and corroborated with HRCT findings like any of the following five patterns-ground glass opacities, miliary pattern, reticular patterns, reticulonodular pattern, and honey-combing were included in the study.

Exclusion criteria: Patients with pre-existing cardiac conditions and other respiratory conditions other than ILDs leading to PAH were excluded from the study.

Sample size calculation: The following formula was used.

N=Z2 *P(1-P)/d2, considering the ILD prevalence rate of 6.27 per lac (8) and precision (d) of 0.10. The final sample size was 22.

Study Procedure

After informed consent was taken, a detailed history was obtained and a thorough clinical examination was conducted. Modified Kuppuswamy classification was used to assess the socio-economic status of the study population (9). Radiological findings and other relevant laboratory investigations were done. Each patient was subjected to a CXR, ECG and 2-D ECHO, and evidence of PAH in any one investigation was considered for the study. The independent variables like age, gender, height, weight, Body Mass Index (BMI), socio-economic status, duration of symptoms, and the extent of disease in High-resolution Computed Tomography (HRCT), and dependent variables were degree of PAH. The degree of PAH was estimated on the basis of Right Ventricular Systolic Pressure (RVSP) as none (RVSP <40 mmHg), mild (RVSP 40-50 mmHg), moderate (RVSP 50-60) mmHg), or severe (RVSP >60 mmHg) (10).

The ECG findings of right ventricular enlargement like R wave (R)> S wave (S) in V1/V2 chest leads and right axis deviation >110 degrees, R < S in V6/L1 and R in V1/V2 plus S in V5/V6>11 mm were considered positive for PAH. Chest radiograph showing dilatation of the pulmonary artery with an increased cardiothoracic ratio was one of the criteria for diagnosing PAH. Moreover, 2-D ECHO was performed to estimate the RVSP. RVSP of >40 mmHg was considered for PAH.

Statistical Analysis

All the data were statistically analysed by using IBM SPSS version 20.0. Descriptive data were expressed as mean±standard deviation and percentages. Data were tabulated and graphically represented. The Chi-square test was used to assess the association of various categorical variables. The logistic regression method was used to determine the predictors. A p-value <0.05 was considered statistically significant.

Results

Most of the patients were in the age group of 70-79 years (Table/Fig 1). The mean age of the study population was 59.7 years and male to female ratio was 11:12 (Table/Fig 2). All the female patients were house wife’s (n=12), among the male patients, 1 was electrician, 1 was lorry driver, 1 was tailor, 4 were daily wage labourers, and 4 were farmers by occupation (Table/Fig 2). Among all patients, 65% (n=15) of the patients belonged to the upper lower socio-economic class, and 35% (n=8) belonged to the lower class (Table/Fig 2). The mean BMI was 22.4±2.73 (Table/Fig 2). It was noted that the majority, 73.91% (n=17) of the patients in the study were of average build and within the range of normal BMI (18.5-24.9). Among all patients, 21.7% (n=5) patients had diabetes mellitus, and 34.78% (n=8) patients had hypertension (Table/Fig 2). Majority of the study population were non smokers (n=13) (Table/Fig 2). Cough and shortness of breath were the most common presenting symptoms (Table/Fig 3). Digital clubbing was seen in only 17% of patients (Table/Fig 3). The mean duration of symptoms was 12.78±10.95 (Table/Fig 3),(Table/Fig 4). The grade-3 MMRC dyspnoea was seen in 57% of patients [Table/Fig-3,4]. On HRCT examination, a majority had a UIP pattern (Table/Fig 5). All patients in the study were subjected to a 6-MWT and it was observed that more than half of the patients (n=12) could walk 200 metres in 6-minutes (Table/Fig 4),(Table/Fig 6). The mean distance covered by 23 patients in the 6-MWT was 213.91 metres with a standard deviation of 105.06.

Total 15 patients (65%) had PAH based on 2-D echo and 8 patients (35%) did not have any evidence of PAH, 7 (30%) patients have moderate PAH as assessed by 2D Echo by measuring RVSP (Table/Fig 6). The mean RVSP value as assessed by 2D Echo was 49.65 mmHg with a standard deviation of 13.72. The median RVSP was 46 mmHg.

Discussion

The mean age of study participants in the present study was 59.7. The suffering of middle-aged people with ILD is evident in the Indian prospective ILD registry by Singh S et al., (1). A study by Lettieri CJ et al., revealed a mean age of 56 years in patients of ILD with PAH (2). Slight female preponderance among index study was observed, participants and similar observations have been reported in various other studies conducted on ILD patients (1),(4),(12). The median RVSP in the 2D echo study in present study group was 46 mmHg. This observation agrees with the observation of the study by Teramachi R et al., where the median RVSP value was 47 mmHg, in their study of 125 ILD patients (13).

All patients in the present study belonged to lower and upper-lower socio-economic groups (as per the modified Kuppuswamy classification of Socio-economic status) (9). This was because the study institution caters to mostly rural and semi-urban catchment areas nearby. All female patients were housewives, and most of the males were either daily wage laborers or farmers by occupation. Hence socio-economic status may not be considered a predictor of the development of PAH in ILD in the setup. None of the earlier studies could establish any significant correlation between socio-economic status and ILD (14),(15). The BMI of most of the study participants was in the range of average (Mean BMI=22.4 Kg/m2).

This observation agrees with the inferences made in studies of various other authors (13),(16). In a study by Yogeshwaran A et al., the mean BMI was 28 in ILD patients with severe pulmonary hypertension (17). There was no significant relationship between 15age, gender, socio-economic status, height, weight, and BMI with the severity of PH (Table/Fig 1). A study by Anderson CU et al., also could not establish any statistically significant relationship between parameters like BMI, gender, and socio-economic status with the prevalence of PH but they found the mean age of ILD patients was higher (65 years) than those without PH (60 years) (4).

Cough and shortness of breath were the most common presenting symptoms in the present study population, similar to other studies (12),(18),(19). It can be inferred that interstitial involvement leads to cough and patients attend the tertiary care centre mostly after developing shortness of breath. The mean duration of symptoms of patients in the present study was 12.78 months, where 47% of them presented within 6 months of the onset of symptoms. Only 30% of patients presented with PAH after one year of symptoms. But many studies conducted earlier observed patients’ presentation after three years of starting symptoms (1),(12),(20). Geographical, social, and cultural factors might have led to early presentation in the present study. There was a positive correlation between the duration of symptoms and RVSP values in the present study. In the linear regression model also, the duration of presenting symptoms was found to be a contributing factor to the development of PAH in patients with ILD. It is inferred from these observations that the longer the duration of symptoms, the more severe the PH.

The mean mMRC grade was 2.73 and 57% of them presented with dyspnoea of grade-3 mMRC. The higher grade of dyspnoea in the series may be because of the presence of PAH in them. The mean dyspnoea grading among 101 ILD patients in the retrospective study by Kimura M et al., was only 1.5 (16). The present study found that when the patients had higher mMRC grades, there were higher RVSP values. It is observed that when patients present with a severe grade of dyspnea severity of pulmonary hypertension is more indicated by high RVSP values. Kimura M et al., noted similar statistically significant observations which indicated a higher grade of mMRC in patients with PAH (16). Hypertension was more often noted in patients with severe PAH and there is an increasing trend toward diabetes mellitus as per the report given by Shorr AF et al., (21). In this study, also 35% of patients had hypertension and 21% had diabetes. Among all patients, 43% were active smokers. The percentage of active smokers varies between different studies. The proportion of non smokers was more in other studies (22),(23). On clinical examination, clubbing was observed in only 17% of study participants. In earlier studies by Kumar R et al., and Nadrous HF et al., also the prevalence of clubbing among ILD patients was less than 20% (12),(23). High-resolution CT scans of patients revealed a UIP pattern in 57% of patients and an Non Specific Interstitial (NSIP) pattern in only 35%. In the Indian prospective ILD registry, only 24% of patients have UIP patterns and 14% have NSIP patterns (1). This discrepancy might be due to the smaller sample size in the index series. Also, the causes of ILD in these patients are different from case to case.

The mean distance walked by the patients in the 6-MWT was 213.9 metres which is almost similar to the observation made by Yogeshwaran A et al., (214 metres) (17). The patients with PAH could walk shorter distances in the test. There was a negative correlation between the 6-MWT distance and RVSP values in the present study (p<0.001). A similar observation was found in the study of Anderson CU et al., (p=0.01) in a series of 212 patients (4). They also mentioned that compared to patients without PAH, PAH patients had shorter 6MWD. They also suggested that a 6-MWT distance below 345 metres is an independent risk factor for PH. A negative correlation was also observed between oxygen saturation after 6-MWT and RVSP values as depicted by Pearson correlation (Pearson correlation-0.649; p=0.01). The logistic regression method revealed that postwalk oxygen desaturation is also a factor in the development of PH (p 0.001). Lettieri CJ et al., also observed a similar correlation between oxygen desaturation after 6-MWT and PH, they also obtained a statistically significant correlation (p=<0.001). They noted that patients with pulmonary hypertension had greater desaturation after 6-MWT (2).

Limitation(s)

Sample size was less and more of the seriously ill patients might have led to selection bias in sampling. Proper measurement of PAH needs right heart catheterisation, but being an invasive procedure this was not used. To assess the risk factors for the development of PAH, a prospective study could have given more information than the present cross-sectional study.

Conclusion

Early recognition of risk factors in patients with ILDs and the prompt treatment of the disease can reduce the development of severe pulmonary hypertension. Factors like delayed seeking of medical care, co-morbidity like hypertension, higher grades of dyspnoea at the time of presentation, shorter 6MWD, and postwalk oxygen saturation are predictors of pulmonary artery hypertension in patients with ILDs. So, early diagnosis, and prompt initiation of treatment may prevent the development of this complication. Adequate pulmonary rehabilitation will help increase in quality of life of these patients. A large, multi-centric prospective study may give us more information, help in further risk factor identification, and can enhance treatment outcomes in patients with ILD having pulmonary hypertension.

References

1.
Singh S, Collins BF, Sharma BB, Joshi MJ, Talwar D, Katiyar S. ILD in India: The ILD-India Registry. Am J Respir Crit Care Med. 2017;195(6):801-13. [crossref][PubMed]
2.
Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129:746-52. [crossref][PubMed]
3.
Corris P, Degano B. Severe pulmonary arterial hypertension: Treatment options and the bridge to transplantation. Eur Respir Rev. 2014;23:488-97. [crossref][PubMed]
4.
Anderson CU, Malllemkjaer S, Hilberg O, Nielsen-Kudsk JE, Simonsen U, Bendstrup E. Pulmonary hypertension in interstitial lung disease: Prevalence, prognosis, and 6 min walk test. Respiratory Medicine. 2012;106:e875-82. [crossref][PubMed]
5.
Tedford RJ, Mudd JO, Girgis RE, Mathai SC, Zaiman AL, Housten-Harris T, et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail. 2013;6(5):953-63. Doi: 10.1161/ CIRCHEARTFAILURE.112.000008. PMID: 23797369; PMCID: PMC3815697. [crossref][PubMed]
6.
Morrisroe K, Huq M, Stevens W, Rabusa C, Proudman SM, Nikpour M; Australian Scleroderma Interest Group (ASIG). Risk factors for the development of pulmonary arterial hypertension in Australian systemic sclerosis patients: Results from a large multicenter cohort study. BMC Pulm Med. 2016;16(1):134. Doi: 10.1186/s12890-016-0296-z. PMID: 27677579; PMCID: PMC5039932. [crossref][PubMed]
7.
Ryu JH, Krowka MJ, Pellikka PA, Swanson KL, McGoon MD. Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc. 2007;82(3):342-50. Doi: 10.4065/82.3.342. PMID: 17352370. [crossref][PubMed]
8.
Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994;150:967-72. [crossref][PubMed]
9.
Ain SN, Khan ZA, Gilani MA. Revised kuppuswamy scale for 2021 based on new consumer price index and use of conversion factors. Indian J Public Health. 2021;65(4):418-21. Doi: 10.4103/ijph.ijph_1108_21. PMID: 34975091. [crossref][PubMed]
10.
Polomis D, Runo JR, Meyer KC. Pulmonary hypertension in interstitial lung disease. Curr Opin Pulm Med. 2008;14(5):462-69. PMID: 18664977. [crossref][PubMed]
11.
Launois C, Barbe C, Bertin E, Nardi J, Perotin JM, Dury S, et al. The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: A pilot study. BMC Pulm Med. 2012;12:61. [crossref][PubMed]
12.
Kumar R, Gupta N, Goel N. Spectrum of interstitial lung disease at a tertiary care center in India. Pneumonol Alergol Pol. 2014;82(3):218-26. PMID: 24793149. [crossref][PubMed]
13.
Teramachi R, Taniguchi H, Kondoh Y. Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease. Respir Investig. 2021;59(3):342- 49. Epub 2021 Feb 10. PMID: 33579646. [crossref][PubMed]
14.
Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, et al; ERAS (Early Rheumatoid Arthritis Study). Interstitial lung disease has a poor prognosis in rheumatoid arthritis: Results from an inception cohort. Rheumatology (Oxford). 2010;49(8):1483-89. Doi: 10.1093/rheumatology/keq035. Epub 2010 Mar 11. PMID: 20223814. [crossref][PubMed]
15.
Sahni S, Talwar A, Khanijo S, Talwar A. Socioeconomic status and its relationship to chronic respiratory disease. Adv Respir Med. 2017;85(2):97-108. Doi: 10.5603/ ARM.2017.0016. PMID: 28440535. [crossref][PubMed]
16.
Kimura M, Taniguchi H, Kondah Y, Kimura T, Kataoka K, Nishiyama O, et al. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis. Respiration. 2013;85(6):456-63. Epub 2012 Dec 19. PMID: 23257350. [crossref][PubMed]
17.
Yogeswaran A, Tello K, Faber M, Sommer N, Kuhnert S, Seeger W, et al. Risk assessment in severe pulmonary hypertension due to interstitial lung disease. J Heart Lung Transplant. 2020;39(10):1118-25. Epub 2020 Jun 25. PMID: 32690230. [crossref][PubMed]
18.
Ghimire RH, Ghimire A, Bimali A, Bista B. Clinical profile and survival rate of interstitial lung disease in a tertiary care center of eastern Nepal. Kathmandu Univ Med J (KUMJ). 2019;17(67):212-16. PMID: 33305750.
19.
Agarwal M, Gupta ML, Deokar K, Shadrach BJ, Bharti N, Sonigra M. Clinico- radiological profile of connective tissue disease related-interstitial lung diseases from a tertiary care center of India: A cross-sectional study. Monaldi Arch Chest Dis. 2021;91(4). Doi: 10.4081/monaldi.2021.1624. PMID: 33840179. [crossref]
20.
Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: Insights- IPF registry. Respir Res. 2017;18(1):139. PMID: 28709421; PMCID: PMC5512739. [crossref][PubMed]
21.
Shorr AF, Wainright JL, Cors CS, Lettieri CJ, Nathan SD. Pulmonary hypertension in patients with pulmonary fibrosis awaiting a lung transplant. Eur Respir J. 2007;30:715-21. [crossref][PubMed]
22.
Almeida RF, Watte G, Marchiori E, Altmayer S, Pacini GS, Barros MC, et al. High-resolution computed tomography patterns in interstitial lung disease (ILD): Prevalence and prognosis. J Bras Pneumol. 2020;46(5):e20190153. PMID: 32159601; PMCID: PMC8648400. [crossref][PubMed]
23.
Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest. 2005;128:2393-99.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/60250.17734

Date of Submission: Sep 15, 2022
Date of Peer Review: Nov 11, 2022
Date of Acceptance: Jan 24, 2023
Date of Publishing: Apr 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Sep 20, 2022
• Manual Googling: Dec 29, 2022
• iThenticate Software: Jan 06, 2023 (7%)

AUTHOR DECLARATION: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com